+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Over the Counter (OTC) Drugs Market 2019-2025

  • PDF Icon


  • June 2020
  • Region: Global
  • Orion Market Research Private Limited
  • ID: 5129888
Global Over the Counter (OTC) Drugs Market Size, Share & Trends Analysis Report By Product Type (Analgesics & Pain Relievers; Cough, Cold & Flu Products; Vitamin & Mineral Supplements; Ophthalmic Products; and Others), By Distribution Channel (Retail & Supermarkets and Online Platform), and Forecast 2019-2025.

The global Over the Counter (OTC) drugs market is anticipated to grow significantly during the forecast period. Over the Counter drugs are purchased directly between two parties, without the supervision of an exchange or prescription by physician. OTC drugs don’t require any clinical trials. The factor contributing to the growth of the market includes the affordable price of OTC drugs across the globe. Further, the availability of OTC drugs on online distribution channel tends to create an opportunity for the future growth of the market.

The global Over the counter (OTC) drugs market is segmented based on product type and distribution channel. Based on the product type, the market is sub-segmented into the analgesics & pain relievers; cough, cold & flu products; vitamin & mineral supplements; ophthalmic products; and others. Vitamin & mineral supplements segment is estimated to exhibit considerable growth rate during the forecast period owing to the increasing awareness among the general population regarding health. Based on the distribution channel, the market is bifurcated into retail & supermarkets and online platform. Online distribution channel is estimated to grow at a significant rate during the forecast period owing to the growing e-commerce industry coupled with increasing internet penetration.

Geographically, the study of the global over the counter (OTC) drugs market report covers the analysis of four major regions including North America (the US and Canada), Europe (UK, Germany, Italy, Spain, France, and Rest of Europe), Asia-Pacific (China, Japan, India, and the Rest of Asia-Pacific), and the Rest of the World. Asia-Pacific is estimated to exhibit a significant growth rate in the global over the counter (OTC) drugs market during the forecast period. The increasing geriatric population in the region drives the growth of the market. In addition, improving healthcare infrastructure further gives a boost to the regional growth of the market.

Moreover, the study of the global over the counter (OTC) drugs market report covers the analysis of various players operating in the market. Some of the key players covered in the report include Bayer AG, GlaxoSmithKline Plc, Novartis International AG, Merck KGaA, Pfizer Inc., Sanofi SA, Sun Pharmaceutical Industries Ltd., and others.

Research Methodology

The market study of the global OTC drugs market is incorporated by extensive primary and secondary research. Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. The team collects facts and data related to the market from different geography to provide a better regional outlook.

In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior, and macro-economic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables the analyst to derive the closest possible figures without any major deviations in the actual number. The analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings authenticity to the reports.

Secondary Sources Include:
  • Financial reports of companies involved in the market.
  • Whitepapers, research-papers, and news blogs.
  • Company websites and their product catalog.

The report is intended for the government organizations, pharmaceuticals companies, pharmacies and other related industries for overall market analysis and competitive analysis. The report provides an in-depth analysis of market size, intended quality of the service preferred by consumers. The report will serve as a source for a 360-degree analysis of the market thoroughly integrating different models.

Market Segmentation:

1. Global Over the Counter (OTC) drugs Market Research and Analysis by Product Type

The Report Covers
  • Comprehensive research methodology of the global OTC drugs market.
  • This report also includes a detailed and extensive market overview with key analyst insights.
  • An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
  • Analysis of regional regulations and other government policies impacting the global OTC drugs market.
  • Insights about market determinants which are stimulating the global OTC drugs market.
  • Detailed and extensive market segments with regional distribution of forecasted revenues.
  • Extensive profiles and recent developments of market players.

Table of Contents

1. Report Summary
1.1. Research Methods and Tools
1.2. Market Breakdown
1.2.1. By Segments
1.2.2. By Geography
2. Market Overview and Insights
2.1. Scope of the Report
2.2. Analyst Insight & Current Market Trends
2.2.1. Key Findings
2.2.2. Recommendations
2.2.3. Conclusion
2.3. Rules & Regulations
3. Competitive Landscape
3.1. Company Share Analysis
3.2. Key Strategy Analysis
3.3. Key Company Analysis
3.3.1. Bayer AG Overview Financial Analysis SWOT Analysis Recent Developments
3.3.2. GlaxoSmithKline Plc Overview Financial Analysis SWOT Analysis Recent Developments
3.3.3. Novartis International AG Overview Financial Analysis SWOT Analysis Recent Developments
3.3.4. Pfizer, Inc Overview Financial Analysis SWOT Analysis Recent Developments
3.3.5. Sanofi SA Overview Financial Analysis SWOT Analysis Recent Developments
4. Market Determinants
4.1 Motivators
4.2 Restraints
4.1. Opportunities
5. Market Segmentation
5.1. Over the Counter (OTC) drug Market by Product Type
5.1.1. Analgesics and Pain Relievers
5.1.2. Cough, Cold and Flu Products
5.1.3. Vitamin & Mineral Supplements
5.1.4. Ophthalmic Products
5.1.5. Others
5.2. Over the Counter (OTC) drug Market by Distribution Channel
5.2.1. Retail & Supermarket
5.2.2. Online Platform
6. Regional Analysis
6.1. North America
6.1.1. US
6.1.2. Canada
6.2. Europe
6.2.1. UK
6.2.2. Germany
6.2.3. Italy
6.2.4. Spain
6.2.5. France
6.2.6. Rest of Europe
6.3. Asia-Pacific
6.3.1. China
6.3.2. India
6.3.3. Japan
6.3.4. Rest of Asia-Pacific
6.4. Rest of the World
7. Company Profiles
7.1. Achelios therapeutics., Inc.
7.2. Alkem Laboratories Ltd.
7.3. Amgen Inc.
7.4. Amway Corp.
7.5. AstraZeneca PLC
7.6. Bayer AG
7.7. Boehringer Ingelheim International GmbH
7.8. Bristol-Myers Squibb Co.
7.9. Cipla Ltd.
7.10. Dr. Reddy’s Laboratories Ltd.
7.11. GlaxoSmithKline Plc
7.12. Glenmark Pharmaceuticals Ltd
7.13. Johnson & Johnson Services, Inc.
7.14. Merck KGaA
7.15. Novartis International AG
7.16. Perrigo Co. plc
7.17. Pfizer, Inc
7.18. Reckitt Benckiser Group plc
7.19. Sanofi SA
7.20. Sun Pharmaceutical Industries Ltd.
7.21. Teva Pharmaceutical Industries Ltd.

Companies Mentioned

A selection of companies mentioned in this report includes:

  • Achelios therapeutics., Inc.
  • Alkem Laboratories Ltd.
  • Amgen Inc.
  • Amway Corp.
  • AstraZeneca PLC
  • Bayer AG
  • Boehringer Ingelheim International GmbH
  • Bristol-Myers Squibb Co.
  • Cipla Ltd.
  • Dr. Reddy’s Laboratories Ltd.
  • GlaxoSmithKline Plc
  • Glenmark Pharmaceuticals Ltd
  • Johnson & Johnson Services, Inc.
  • Merck KGaA
  • Novartis International AG
  • Perrigo Co. plc
  • Pfizer, Inc
  • Reckitt Benckiser Group plc
  • Sanofi SA
  • Sun Pharmaceutical Industries Ltd.
  • Teva Pharmaceutical Industries Ltd.